Clinical Trials Browser

Phase 3 × NIH × pazopanib × Clear all

NCT01575548 2026-04-13

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Phase 3 Active not recruiting

129 enrolled 11 charts

Carcinoma, Renal Cell